Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Dutasteride and finasteride don't raise erectile dysfunction risk.

Using dutasteride during hair transplants improves results and reduces hair loss.

The new dutasteride formula can be applied to the skin, may promote hair growth, and has fewer side effects.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

The combination of oral finasteride and dutasteride with topical minoxidil effectively promotes new hair growth in most people, with minimal side effects.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Dutasteride may help prevent prostate cancer, but more research is needed.

Finasteride and dutasteride effectively treat hair loss, with dutasteride showing slightly better results.

Finasteride and dutasteride effectively treat hair loss, with dutasteride showing slightly better results.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Mesotherapy with dutasteride improves hair growth and reduces symptoms in frontal fibrosing alopecia.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Dutasteride and minoxidil mesotherapy effectively treats hair loss with minimal side effects.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Intralesional dutasteride improves hair growth in androgenic alopecia with minimal side effects.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

Finasteride causes fewer sexual side effects than dutasteride in men with BPH.